Jim Simons Annexon, Inc. Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Annexon, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 401,400 shares of ANNX stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
401,400
Previous 584,200
31.29%
Holding current value
$2.1 Million
Previous $2.86 Million
16.98%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ANNX
# of Institutions
146Shares Held
102MCall Options Held
178KPut Options Held
159K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$44.2 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$38.7 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$36.6 Million1.32% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$34.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$33.6 Million2.49% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $249M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...